Prestige Consumer Healthcare (PBH) Accumulated Expenses (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Accumulated Expenses of $15.1 million for Q4 2025, down 75.25% year-over-year from $60.9 million in Q4 2024, and down 3.21% quarter-over-quarter from $15.6 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Accumulated Expenses (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Accumulated Expenses history runs 15 years deep, the most recent figure standing at $15.1 million for Q4 2025.
- In Q4 2025, Accumulated Expenses fell 75.25% year-over-year to $15.1 million; the TTM figure through Dec 2025 stood at $15.1 million (down 75.25% YoY), while the FY2025 annual figure was $63.5 million, up 302.58% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $15.1 million, down from $15.6 million in the prior quarter.
- The five-year high for Accumulated Expenses was $74.1 million in Q1 2022, with the low at $6.3 million in Q1 2021.
- The 5-year median for Accumulated Expenses is $16.6 million (2021), against an average of $37.9 million.
- The sharpest annual moves came in 2021 and 2022: Accumulated Expenses slumped 91.08% in 2021, then soared 1074.16% in 2022.
- Prestige Consumer Healthcare's Accumulated Expenses stood at $15.1 million in 2021, then jumped by 369.59% to $71.0 million in 2022, then plunged by 78.59% to $15.2 million in 2023, then soared by 300.84% to $60.9 million in 2024, then sank by 75.25% to $15.1 million in 2025.
- Business Quant data shows PBH's Accumulated Expenses at $15.1 million in Q4 2025, $15.6 million in Q3 2025, and $15.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.42 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.99 Mn |
| Dec 31, 2025 | 15.08 Mn |
| Sep 30, 2025 | 15.58 Mn |
| Jun 30, 2025 | 15.08 Mn |
| Mar 31, 2025 | 63.46 Mn |
| Dec 31, 2024 | 60.92 Mn |
| Sep 30, 2024 | 15.71 Mn |
| Jun 30, 2024 | 54.86 Mn |
| Mar 31, 2024 | 15.76 Mn |
| Dec 31, 2023 | 15.20 Mn |
| Sep 30, 2023 | 60.08 Mn |
| Jun 30, 2023 | 15.19 Mn |
| Mar 31, 2023 | 72.52 Mn |
| Dec 31, 2022 | 70.98 Mn |
| Sep 30, 2022 | 70.98 Mn |
| Jun 30, 2022 | 15.18 Mn |
| Mar 31, 2022 | 74.11 Mn |
| Dec 31, 2021 | 15.12 Mn |
| Sep 30, 2021 | 17.53 Mn |
| Jun 30, 2021 | 68.44 Mn |